Related Experiment Video
Updated: Jan 17, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
AI-driven dynamic grouping for adaptive clinical trials: Rethinking randomization in precision medicine
1Department of Biomechanics, University of Nebraska at Omaha, Omaha, NE 68182, USA.
Artificial intelligence (AI) enables dynamic grouping in biomedical research, continuously reassigning participants based on real-time data. This approach optimizes treatment effectiveness and resource allocation in clinical trials and precision medicine.
Area of Science:
- Biomedical research
- Artificial intelligence
- Clinical trials
Background:
- Traditional biomedical research relies on fixed participant groups.
- Artificial intelligence (AI) offers new paradigms for human subjects research.
- Dynamic grouping represents a novel AI-driven approach to experimental design.
Purpose of the Study:
- Introduce and examine the concept of dynamic grouping in AI-driven biomedical research.
- Analyze the ethical, methodological, and research implications of dynamic grouping.
- Quantify the impact of dynamic grouping through computational simulations.
Main Methods:
- Developed a novel concept of dynamic grouping using AI for participant reassignment.
- Conducted three computational simulations: heterogeneity, statistical power, and clinical outcome analysis.
- Examined ethical considerations, methodological challenges, and research opportunities.
Main Results:
- Dynamic grouping improves treatment effectiveness and optimizes patient responses.
- Potential for sample size reduction in adaptive clinical trial designs.
- Enhanced resource allocation and statistical efficiency demonstrated through simulations.
Conclusions:
- Dynamic grouping offers significant advantages for biomedical research, including improved outcomes and efficiency.
- New challenges in causal inference, informed consent, and regulatory oversight require attention.
- Adapting ethical and methodological frameworks is crucial for responsible AI implementation in medical research.
More Related Videos
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Hazard Ratio
For example, in a clinical trial...
Cancer Survival Analysis